source
- FDA panel backs compounding pharmacies to make two peptides, rejects thirdThe U.S. Food and Drug Administration’s advisory committee met on Friday and issued recommendations on the manufacturing of certain peptide drugs by compounding pharmacies. Committee members voted…
- AstraZeneca says Wainua failure won’t alter M&A plans, stays on track for $80B 2030 goalAstraZeneca said during its Q2 earnings presentation that the late‑stage failure of the antisense therapy Wainua in ATTR‑cardiomyopathy does not derail its goal of reaching $80 billion in revenue b…